Angiotensin-converting enzyme inhibitors can be a risk factor for lung cancer!!

Simple item page
dc.contributor.authorAltalhe, Heba Abdalnasser Azouz
dc.date.accessioned2019-06-25T09:09:41Z
dc.date.available2019-06-25T09:09:41Z
dc.date.issued2019-04-09
dc.descriptionAngiotensin converting enzyme inhibitors (ACE inhibitors) are medications that inhibit the activity of the enzyme ACE, which decreases the production of angiotensin II. As a result, blood vessels dilate, and blood pressure is reduced ,the are effective drugs used in the treatment of hypertension[1]. Although these drugs have been shown to be relatively safe in the short term, concerns have been raised that their long term use may be associated with an increased risk of cancer. [2],The Some biological evidence exists for a possible association between ACEIs and risk of lung cancer.en_US
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/991
dc.language.isoenen_US
dc.publisherfaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleAngiotensin-converting enzyme inhibitors can be a risk factor for lung cancer!!en_US
dc.typeOtheren_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Libyan International Medical University poster 2017-2018 (1).pdf
Size:
662.77 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Posters